Suchergebnisse - "Singer, Barry A."

PubPharm (39)

1

Early use of high-efficacy therapies in multiple sclerosis in the United States : benefits, barriers, and strategies for encouraging adoption

enthalten in: Journal of neurology | 2024

von Singer, B. | Feng, J. | Chiong-Rivero, H.

2

Diroximel fumarate in patients with relapsing-remitting multiple sclerosis : Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2023

von Singer, B. | Arnold, D. | Drulovic, J. | +20

3

Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis : final results from the open-label TOPAZ study

enthalten in: Therapeutic advances in neurological disorders | 2023

von Coles, A. | Achiron, A. | Traboulsee, A. | +12

4

Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis : Findings from Qualitative Research Using Patient Interviews

enthalten in: Advances in therapy | 2022

von Gudesblatt, M. | Roman, C. | Singer, B. | +5

5

Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets : The CLARITY extension study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Giovannoni, G. | Singer, B. | Issard, D. | +2

CommentIn: Nat Rev Neurol. 2021 Dec;17(12):726. - PMID 34732828

6

Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews

enthalten in: Advances in therapy | 2022

von Gudesblatt, M. | Roman, C. | Singer, B. | +5

7

Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews

enthalten in: Advances in therapy | 2022

von Gudesblatt, M. | Roman, C. | Singer, B. | +5

8

Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews

enthalten in: Advances in therapy | 2022

von Gudesblatt, M. | Roman, C. | Singer, B. | +5

9

Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF : Results from the Phase 3 EVOLVE-MS-1 Study

enthalten in: Advances in therapy | 2022

von Wray, S. | Then Bergh, F. | Wundes, A. | +14

10

Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study

enthalten in: Advances in therapy | 2022

von Wray, S. | Then Bergh, F. | Wundes, A. | +14